She now thinks it could be done in months, thanks to a new initiative by the U.S. Food and Drug Administration to use medical device-based treatments, diagnostic tests and mobile medical apps to address the country's opioid crisis.
When President Donald Trump declared a public health emergency over the abuse of heavy-duty painkillers like oxycodone and hydrocodone, he ordered all government agencies to take action in response to the death of 70,000 Americans last year from drug overdoses.
The FDA told Reuters it has received over 200 submissions from companies seeking a speedy approval process for their devices. These range from Stimwave's Halo to painkilling products made by Abbott Laboratories and other industry heavyweights as an alternative to opioids.
"We're pleased by the robust interest in this innovation challenge and the acknowledgement from developers about the unique and important role medical devices, including digital health technologies like mobile medical apps, have the potential to play in tackling the opioid crisis," FDA Commissioner Scott Gottlieb said.
Perryman's Halo devices, which look like angel hair pasta and are so small they can be injected into a nerve, took four years to get U.S. approval under other names for easing leg and back pain.
She hopes a spot on the FDA program will see Halo approved within a year as an alternative to opioids, which are currently used to treat an estimated 50 percent of patients who come to emergency rooms with migraines.
"This is kind of perfect for something like ours...since the device is shown to be safe already," said Perryman, who founded privately-held Stimwave in South Florida seven years ago.
The FDA has been increasingly reluctant to greenlight new opioids for market but earlier this month approved a potent opioid-based painkiller from AcelRx Pharmaceuticals Inc placing tight restrictions on its distribution and use. In a rare move, Gottlieb made a public statement at the time, explaining the decision.
The regulator's push for alternatives to opioids has helped drive interest from venture capital funds and institutional investors this year in firms promising to develop alternatives, according to interviews with device companies, financial services firms and brokerage Cowen & Co.
For example, privately-held Virpax Pharmaceuticals, which makes an aerosol spray that delivers a non-opioid pain drug, said it had four or five banks interested in running its Series A investment round this summer versus just one in the past.
Abbott, like rivals Boston Scientific Corp and Nevro Corp, makes neuromodulation implants which stimulate the nervous system to mask pain signals before they reach the brain.
Abbott has submitted an entry for the competition in the hope it will slash waiting times, which often stretch several months just to get an initial meeting, according to Dr. Allen Burton, Abbott's medical director of neuromodulation.
"Devices that are part of this (program) will be streamlined... their meeting will go to the top of the pile," said Burton.
While neuromodulation is only a small part of Abbott's large medical device business, the unit is seen as a growth engine for the company. Burton estimates between 10-to-20 percent of the growth Abbott has seen in its neuromodulation business could be tied to doctors prescribing its devices for pain after surgery or from injury to patients that are opioid averse.
Boston Scientific did not apply for the contest, but the company is investing "heavily" in its neuromodulation unit, which was its fastest-growing at nearly 23 percent in the latest quarter, according to Maulik Nanavaty, senior vice president at the device maker.
"We continue to make external investments in early (neuromodulation) technology," he told Reuters.
To be sure, these devices are not seen as a silver bullet for opioid addiction. Nirad Jain, a partner at consulting firm Bain & Co, believes many of the solutions on the table are just tinkering at the edges of a problem that needs to be solved by doctors simply settling for fewer or less potent opioids.
Academics and charitable groups dealing with the social fallout of the crisis say the bulk of the rise in deaths stems from misuse of prescription painkillers. That has put the onus on regulators in September to issue new rules cracking down on prescribing by doctors.
"The goal is that these guidelines will provide evidence-based information on the proper number of opioid doses that should be dispensed," Gottlieb said in a statement at the time.
"Our goal is to help prevent patients from becoming addicted by decreasing unnecessary or inappropriate exposure to opioids." Although the FDA contest is limited to devices and app-based solutions for pain and addiction, the current regulatory climate is also conducive to companies developing opioid-alternative pharmaceuticals.
Drugmakers including Pfizer Inc, Eli Lilly and Co, Regeneron Pharmaceuticals Inc and Teva Pharmaceutical Industries Inc have been packing their pipelines with potential solutions to the crisis and there are 120 non-opioid drugs under FDA review this year, up some 650 percent since 2013, according to business intelligence firm Informa.
(Non-opioid drug applications surge png, tmsnrt.rs/2ReUI2H Privately-held SPR Therapeutics Inc told Reuters it has entered its "temporary" neuromodulation device in the contest. Similarly to Stimwave's, its product is implanted into the body but can be surgically removed after about two months. Josh Boggs, a senior executive at the company, expects to get quicker feedback from the FDA and shorter review times in the wake of the crisis.
After years in the business, he believes the crisis has increased the agency's desire to collaborate with medical technology companies like his.
"I feel like (FDA) people are coming well prepared to meetings and are very engaged in it. It feels like an atmosphere that's conducive to finding a solution," he said.
(The story corrects third paragraph to say the deaths were from drug overdoses, not specifically opioid overdoses)
Kung mayroon kang a
Tanong,
Mangyaring makipag-ugnay sa pakikipag-ugnayan
Info@mecanmedical.com
{"site":{"site_id":2622,"site_type":1,"site_domain":"medical-hospital-equipment.com","domain_mode":2,"original_domain":"medical-hospital-equipment.com","language_code":"tl","is_init_domain":0,"is_ssl":0,"lang_prefix":"/tl","animate_name":"none","compress__ratio":"75,60,60"},"page":{"page_id":49814,"page_type":"ai_article_detail","page_code":423,"page_url":"/ai-article/u-s-regulators-snip-red-tape-for-medical-devices-to-curb-opioid-crisis.html","page_source":"","allowAnimat":0,"content_id":997,"content_type":5,"detail_thumb":"https://img.yfisher.com/1615810384399.jpg","detail_title":"U.S. Regulators Snip Red Tape for Medical Devices to Curb Opioid Crisis","moq":1},"translateList":{"A new item has been added to your Shopping Cart":"Ang isang bagong item ay naidagdag sa iyong shopping cart","Account is not exists":"Ang account ay hindi umiiral.","Add a review on the product":"Magdagdag ng pagsusuri sa produkto","Add to":"Idagdag sa","Add to Cart":"idagdag sa cart","all":"Lahat","All Orders":"Lahat ng mga order.","Already commented":"Nagkomento na","Are you sure you want to delete it?":"Sigurado ka bang gusto mong tanggalin ito?","Are you sure to delete the selected items?":"Sigurado ka bang tanggalin ang mga napiling item?","Awaiting Payment":"naghihintay ng pagbabayad","Awaiting Shipment":"naghihintay ng kargamento","account security":"Seguridad ng Account","address book":"Address Book.","Buy":"Buy.","Buy Now":"Bumili ka na ngayon","Cancel":"Kanselahin","Clear":"Malinaw","Clear Search":"I-clear ang paghahanap","Confirm":"Kumpirmahin","Choose a country":"Pumili ng Bansa","Choose Coupon":"Pumili ng Kupon.","commodity payment":"Pagbabayad ng kalakal","Completed":"nakumpleto","Condition not met":"Kondisyon na hindi nakasalubong","Confirm password is inconsistent with new password":"Kumpirmahin ang password ay hindi naaayon sa bagong password","Congratulations":"Binabati kita","Congratulations! You are got a coupon.":"Binabati kita! Mayroon kang isang kupon.","Congratulations! You are got all coupons.":"Binabati kita! Mayroon kang lahat ng mga kupon.","Continue Shopping":"ipagpatuloy ang pamimili","Copy the code and use it directly in the shopping cart.":"Kopyahin ang code at gamitin ito nang direkta sa shopping cart.","Coupon List":"Listahan ng Kupon.","Country":"Bansa","Design customization":"Pag-customize ng disenyo","Do not use any discount":"Huwag gumamit ng anumang diskwento","Earliest":"Pinakamaagang","email":"Email","email format does not match":"Ang format ng email ay hindi tumutugma","Estimated Delivery Time":"Tinatayang oras ng paghahatid","expired":"Nag-expire na","Find Parts":"Maghanap ng mga bahagi","Free":"Libre","Free Quote & Information Request":"Libreng quote at kahilingan ng impormasyon","Free Shipping":"Libreng Pagpapadala","for order over":"para sa order over","Get":"Get.","Get coupons":"Kumuha ng mga kupon","Get discount":"Kumuha ng diskwento","Get it":"Kunin mo","Get it after logging in and use it in the shopping cart.":"Kunin ito pagkatapos mag-log in at gamitin ito sa shopping cart.","Go to Page":"Pumunta sa pahina","Highest Price":"Pinakamataas na presyo","Hot Sale":"Hot Sale.","home":"bahay","Incorrect form format":"Maling format ng form.","inquiry":"pagtatanong","Loading":"Loading.","Lowest Price":"Pinakamababang presyo","Match Product":"Tugma produkto","Merchant Free Shipping":"Merchant free shipping.","Most Popular":"Pinaka sikat","my account":"aking Account","my coupons":"ang aking mga kupon","my inquiry":"aking pagtatanong","my orders":"ang aking mga order","my reviews":"aking mga review","my wishlist":"Aking Wishlist","name":"pangalan","Newest":"Pinakabago","No Quotation":"Walang sipi","No time limit":"Walang limitasyon sa oras","Not deleted":"Hindi tinanggal","not valid yet":"hindi wasto pa","Off":"Off.","Offers and Discounts":"Mga alok at diskwento","ok":"Ok.","optional":"opsyonal","Order over":"Order over","order notes":"Mga tala ng order","Password contains at least numbers and letters length should be 6-20":"Ang password ay naglalaman ng hindi bababa sa mga numero at haba ng mga titik ay dapat na 6-20","Password is invalid":"Di-wasto ang password","Password length should be 6-20":"Ang haba ng password ay dapat na 6-20.","Paypal":"Paypal","paypal payment":"PayPal Payment.","personal info":"Personal na impormasyon","Please click ’click to continue’ to retry.":"Paki-click ang \"I-click upang magpatuloy\" upang muling subukan.","Please enter a valid email address":"Mangyaring magpasok ng wastong email address","Please enter the verification code":"Mangyaring ipasok ang verification code","Please login in first":"Mangyaring mag-login muna","Please select attribute":"Mangyaring piliin ang Attribute.","Please select country/region":"Mangyaring piliin ang Bansa / Rehiyon","Please select superior":"Mangyaring pumili ng higit na mataas","Please select the number of ratings.":"Mangyaring piliin ang bilang ng mga rating.","read more":"Magbasa pa","Region":"Rehiyon","Register Success":"Magrehistro ng tagumpay","Sale ends in":"Nagtatapos ang pagbebenta","Save in wishlist":"I-save sa Wishlist","Search":"Search.","Shipping":"Pagpapadala","Shipping Address":"Address ng pagpapadala","shipment successful":"matagumpay na kargamento","Size guide":"Patnubay sa laki","Small Text":"Maliit na teksto","Small Title":"Maliit na pamagat","Sort By":"Pagsunud-sunurin sa pamamagitan ng","State/Province/Territory":"Estado / Lalawigan / Teritoryo.","Successfully delete":"Matagumpay na tanggalin","Successfully save":"Matagumpay na i-save","The coupon code has been copied and used in the shopping cart.":"Ang kupon code ay kinopya at ginagamit sa shopping cart.","The subscription is successful, thank you for your participation":"Ang subscription ay matagumpay, salamat sa iyong paglahok","The user center is out of service. Please contact customer service":"Ang user center ay wala sa serbisyo. Mangyaring makipag-ugnay sa serbisyo sa customer","This is Text":"Ito ay teksto","This is title":"Ito ay pamagat","This transaction has failed.":"Nabigo ang transaksyong ito.","Time to shop":"Oras upang mamili","To be commented":"Na magkomento","Total":"Kabuuan","the content can not be blank":"Ang nilalaman ay hindi maaaring blangko","Update password success":"I-update ang tagumpay ng password","Upload Image":"Mag-upload ng larawan","Upload up to 6 pictures":"Mag-upload ng hanggang sa 6 na larawan","uploading":"Pag-upload","used":"ginamit","user center":"User Center.","Validity period":"Panahon ng bisa","valid now":"wastong ngayon","View Cart & Checkout":"Tingnan ang Cart","Welcome to the website":"Maligayang pagdating sa website.","Western Union":"Western Union.","Write a Review":"Sumulat ng pagsusuri","You are got a coupon.":"Mayroon kang isang kupon.","You haven’t chosen an address yet":"Hindi mo pa pinili ang isang address","You haven’t selected a product yet":"Hindi mo pa napili ang isang produkto","Your rating":"Ang iyong grado ay","Your review":"Ang iyong pagsusuri","Your shipping address error":"Error sa iyong pagpapadala ng address"}}